Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential thrombocythemia during pregnancy

S Eliyahu1, E Shalev

  • 1Department of Obstetrics and Gynecology, Haemek Medical Center, Afula, Israel.

Obstetrical & Gynecological Survey
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enthalpy of collagen interfibrillar bonds in fetal membranes.

Journal of biomechanics·2021
Same author

Collagen bundling and alignment in equibiaxially stretched human amnion.

Journal of biomechanics·2020
Same author

Ectopic pregnancy risk factors for ART patients undergoing the GnRH antagonist protocol: a retrospective study.

Reproductive biology and endocrinology : RB&E·2016
Same author

Delivery of a healthy baby following more than 17 years of pronuclear stage embryos cryopreservation.

European journal of obstetrics, gynecology, and reproductive biology·2012
Same author

Empty follicle syndrome: successful treatment in a recurrent case and review of the literature.

Human reproduction (Oxford, England)·2012
Same author

Effect of primary human endometrial stromal cells on epithelial cell receptivity and protein expression is dependent on menstrual cycle stage.

Human reproduction (Oxford, England)·2010

Essential thrombocythemia, a condition of high platelet count, can lead to adverse pregnancy outcomes. Treatments like aspirin and heparin are reviewed for managing this myeloproliferative disorder during pregnancy.

Area of Science:

  • Hematology
  • Obstetrics
  • Reproductive Medicine

Background:

  • Essential thrombocythemia is a myeloproliferative neoplasm marked by elevated platelet counts.
  • While typically diagnosed in middle age, earlier onset is documented.
  • Pregnancy in women with essential thrombocythemia poses risks such as abortion and fetal growth retardation.

Observation:

  • Increased platelet counts in essential thrombocythemia can lead to thrombosis.
  • Pregnancy complications include abortion, intrauterine fetal death, abruptio placentae, intrauterine growth retardation, and premature delivery.
  • Management strategies during pregnancy aim to reduce platelet count and mitigate thrombotic risk.

Findings:

  • Review of pregnancy outcomes in women with essential thrombocythemia.

Related Experiment Videos

  • Analysis of various treatment modalities employed during pregnancy, including acetylsalicylic acid, dipyridamole, heparin, and plateletpheresis.
  • Evaluation of the efficacy and safety of these treatments in managing essential thrombocythemia during gestation.

    • Implications:

    • Informs clinical decision-making for managing essential thrombocythemia in pregnant patients.
    • Highlights the importance of multidisciplinary care involving hematologists and obstetricians.
    • Contributes to understanding the impact of myeloproliferative disorders on pregnancy and potential therapeutic interventions.